DAFNA Capital Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $448K | Sell |
64,492
-16,307
| -20% | -$113K | 0.12% | 67 |
|
|
2025
Q1 | $686K | Sell |
80,799
-40,000
| -33% | -$340K | 0.19% | 68 |
|
|
2024
Q4 | $1.69M | Sell |
120,799
-1,401
| -1% | -$19.6K | 0.43% | 46 |
|
|
2024
Q3 | $2.77M | Hold |
122,200
| – | – | 0.65% | 40 |
|
|
2024
Q2 | $2.47M | Hold |
122,200
| – | – | 0.59% | 39 |
|
|
2024
Q1 | $3.04M | Hold |
122,200
| – | – | 0.69% | 36 |
|
|
2023
Q4 | $2.21M | Hold |
122,200
| – | – | 0.53% | 41 |
|
|
2023
Q3 | $2.45M | Hold |
122,200
| – | – | 0.76% | 34 |
|
|
2023
Q2 | $3.12M | Hold |
122,200
| – | – | 0.85% | 34 |
|
|
2023
Q1 | $2.6M | Hold |
122,200
| – | – | 0.78% | 36 |
|
|
2022
Q4 | $3.62M | Hold |
122,200
| – | – | 1.02% | 31 |
|
|
2022
Q3 | $2.84M | Sell |
122,200
-9,000
| -7% | -$209K | 0.76% | 35 |
|
|
2022
Q2 | $2.2M | Buy |
131,200
+78,000
| +147% | +$1.31M | 0.6% | 42 |
|
|
2022
Q1 | $2.33M | Buy |
+53,200
| New | +$2.33M | 0.61% | 45 |
|